DIABETIC POLYNEUROPATHY: CURRENT APPROACHES TO DIAGNOSIS AND PATHOGENETIC THERAPY

The paper considers the current views of the prevalence, clinical picture, approaches to the diagnosis and treatment of one of the most commonneurological complications of diabetes mellitus – diabetic polyneuropathy, and both its somatic and autonomous manifestations. Neuropathy ismost common in dia...

Full description

Bibliographic Details
Main Author: O. S. Levin
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Klinicist
Subjects:
Online Access:https://klinitsist.abvpress.ru/Klin/article/view/30
id doaj-0a25663341d943ba9ce7b3030fd9698c
record_format Article
spelling doaj-0a25663341d943ba9ce7b3030fd9698c2021-08-02T08:49:42ZrusABV-pressKlinicist1818-83382014-07-0172546310.17650/1818-8338-2013-7-2-221-23545DIABETIC POLYNEUROPATHY: CURRENT APPROACHES TO DIAGNOSIS AND PATHOGENETIC THERAPYO. S. Levin0Russian Medical Academy of Postgraduate Education, Ministry of HealthThe paper considers the current views of the prevalence, clinical picture, approaches to the diagnosis and treatment of one of the most commonneurological complications of diabetes mellitus – diabetic polyneuropathy, and both its somatic and autonomous manifestations. Neuropathy ismost common in diabetic patients and its clinical forms reflect the severe course of diabetes mellitus and serve as an unfavorable prognostic signthat is associated with an approximately 5-fold increase in mortality. At the same time, the timely detection and adequate correction of the manifestations of neuropathy may substantially improve quality of life in the patients. The possibilities of pathogenetic therapy for diabetic polyneuropathy associated mainly with the use of benfotiamine and alpha-lipoic acid, as well as symptomatic therapy for its individual manifestationsare considered.https://klinitsist.abvpress.ru/Klin/article/view/30diabetes mellituspolyneuropathybenfotiaminealpha-lipoic acid
collection DOAJ
language Russian
format Article
sources DOAJ
author O. S. Levin
spellingShingle O. S. Levin
DIABETIC POLYNEUROPATHY: CURRENT APPROACHES TO DIAGNOSIS AND PATHOGENETIC THERAPY
Klinicist
diabetes mellitus
polyneuropathy
benfotiamine
alpha-lipoic acid
author_facet O. S. Levin
author_sort O. S. Levin
title DIABETIC POLYNEUROPATHY: CURRENT APPROACHES TO DIAGNOSIS AND PATHOGENETIC THERAPY
title_short DIABETIC POLYNEUROPATHY: CURRENT APPROACHES TO DIAGNOSIS AND PATHOGENETIC THERAPY
title_full DIABETIC POLYNEUROPATHY: CURRENT APPROACHES TO DIAGNOSIS AND PATHOGENETIC THERAPY
title_fullStr DIABETIC POLYNEUROPATHY: CURRENT APPROACHES TO DIAGNOSIS AND PATHOGENETIC THERAPY
title_full_unstemmed DIABETIC POLYNEUROPATHY: CURRENT APPROACHES TO DIAGNOSIS AND PATHOGENETIC THERAPY
title_sort diabetic polyneuropathy: current approaches to diagnosis and pathogenetic therapy
publisher ABV-press
series Klinicist
issn 1818-8338
publishDate 2014-07-01
description The paper considers the current views of the prevalence, clinical picture, approaches to the diagnosis and treatment of one of the most commonneurological complications of diabetes mellitus – diabetic polyneuropathy, and both its somatic and autonomous manifestations. Neuropathy ismost common in diabetic patients and its clinical forms reflect the severe course of diabetes mellitus and serve as an unfavorable prognostic signthat is associated with an approximately 5-fold increase in mortality. At the same time, the timely detection and adequate correction of the manifestations of neuropathy may substantially improve quality of life in the patients. The possibilities of pathogenetic therapy for diabetic polyneuropathy associated mainly with the use of benfotiamine and alpha-lipoic acid, as well as symptomatic therapy for its individual manifestationsare considered.
topic diabetes mellitus
polyneuropathy
benfotiamine
alpha-lipoic acid
url https://klinitsist.abvpress.ru/Klin/article/view/30
work_keys_str_mv AT oslevin diabeticpolyneuropathycurrentapproachestodiagnosisandpathogenetictherapy
_version_ 1721237145266421760